Clearpoint Neuro Inc (CLPT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Clearpoint Neuro Inc (CLPT) has a cash flow conversion efficiency ratio of -0.431x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.08 Million) by net assets ($28.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Clearpoint Neuro Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Clearpoint Neuro Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Clearpoint Neuro Inc (CLPT) total liabilities for a breakdown of total debt and financial obligations.
Clearpoint Neuro Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clearpoint Neuro Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Magic Design & Decoration Engineering Co Ltd
SHE:002856
|
-0.234x |
|
SPC Samlip Co Ltd
KO:005610
|
0.073x |
|
ProKidney Corp.
NASDAQ:PROK
|
-0.084x |
|
Anavex Life Sciences Corp
NASDAQ:AVXL
|
-0.056x |
|
NeXGold Mining Corp
V:NEXG
|
-0.046x |
|
Hunan Copote Science Technology Co Ltd
SHG:600476
|
0.282x |
|
Korea Information & Communications Co. Ltd
KQ:025770
|
-0.057x |
|
Cape Industries Ltd
KQ:064820
|
0.310x |
Annual Cash Flow Conversion Efficiency for Clearpoint Neuro Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Clearpoint Neuro Inc from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Clearpoint Neuro Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $28.02 Million | $-23.93 Million | -0.854x | -142.22% |
| 2024-12-31 | $25.39 Million | $-8.95 Million | -0.353x | +45.60% |
| 2023-12-31 | $21.17 Million | $-13.72 Million | -0.648x | -47.85% |
| 2022-12-31 | $36.89 Million | $-16.17 Million | -0.438x | -68.41% |
| 2021-12-31 | $48.79 Million | $-12.70 Million | -0.260x | +92.08% |
| 2020-12-31 | $2.38 Million | $-7.81 Million | -3.285x | -428.66% |
| 2019-12-31 | $4.59 Million | $-2.85 Million | -0.621x | +79.72% |
| 2018-12-31 | $1.51 Million | $-4.63 Million | -3.065x | -198.08% |
| 2017-12-31 | $5.83 Million | $-5.99 Million | -1.028x | -113.36% |
| 2016-12-31 | $-756.07K | $-5.82 Million | 7.698x | +76.55% |
| 2015-12-31 | $-1.98 Million | $-8.64 Million | 4.360x | -93.97% |
| 2014-12-31 | $-100.33K | $-7.25 Million | 72.265x | +6249.42% |
| 2013-12-31 | $-6.83 Million | $-7.78 Million | 1.138x | -12.16% |
| 2012-12-31 | $-5.74 Million | $-7.43 Million | 1.296x | +353.61% |
| 2011-12-31 | $-21.84 Million | $-6.24 Million | 0.286x | -- |
About Clearpoint Neuro Inc
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which … Read more